Trademark: 87977815
Word
NANOSTRING
Status
Registered
Status Code
700
Status Date
Tuesday, August 7, 2018
Serial Number
87977815
Registration Number
5537412
Registration Date
Tuesday, August 7, 2018
Mark Type
3000
Filing Date
Tuesday, March 28, 2017
Published for Opposition
Tuesday, August 22, 2017

Trademark Owner History
NanoString Technologies, Inc. - Original Registrant

Classifications
5 Diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care namely, medical diagnostic reagents for RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
1 Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small- molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small- molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
42 Research and product development services for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of gene expression; genetic data mining; providing molecule identification methods for acquiring, analyzing and managing biological and genetic information, in the fields of genetics and environment; research and development services for others in the field of diagnostic compounds for use in medicine, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes, and industrial quality control processes; developing systems for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, genetics, and environment; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes and industrial quality control processes; chemical screening analysis for others
The mark consists of the word "nanoString" with a line below the word containing circles.
Color is not claimed as a feature of the mark.

Trademark Events
Aug 7, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 18, 2020
Assignment Of Ownership Not Updated Automatically
Aug 7, 2018
Registered-Principal Register
Jun 30, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 29, 2018
Allowed Principal Register - Sou Accepted
Jun 9, 2018
Notice Of Design Search Code E-Mailed
Jun 8, 2018
Statement Of Use Processing Complete
Jun 4, 2018
Use Amendment Filed
Jun 8, 2018
Divisional Processing Complete
Jun 4, 2018
Divisional Request Received
Jun 8, 2018
Case Assigned To Intent To Use Paralegal
Jun 4, 2018
Teas Request To Divide Received
Jun 4, 2018
Teas Statement Of Use Received
Apr 3, 2018
Notice Of Approval Of Extension Request E-Mailed
Mar 30, 2018
Sou Extension 1 Granted
Mar 30, 2018
Sou Extension 1 Filed
Mar 30, 2018
Teas Extension Received
Oct 17, 2017
Noa E-Mailed - Sou Required From Applicant
Aug 22, 2017
Official Gazette Publication Confirmation E-Mailed
Aug 22, 2017
Published For Opposition
Aug 2, 2017
Notification Of Notice Of Publication E-Mailed
Jun 23, 2017
Approved For Pub - Principal Register
Jun 22, 2017
Examiner's Amendment Entered
Jun 22, 2017
Notification Of Examiners Amendment E-Mailed
Jun 22, 2017
Examiners Amendment E-Mailed
Jun 22, 2017
Examiners Amendment -Written
Jun 20, 2017
Assigned To Examiner
Apr 4, 2017
Notice Of Design Search Code E-Mailed
Apr 1, 2017
New Application Office Supplied Data Entered
Mar 31, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24